Average cost of multi drug-resistant tuberculosis treatment in Kyrgyzstan
Kyrgyzstan: Average cost of multi drug-resistant tuberculosis treatment was 1,607 constant 2022 US$ in 2022. ▼ Falling
Average cost of multi drug-resistant tuberculosis treatment in Kyrgyzstan, 2017–2022
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
In 2022, average cost of multi drug-resistant tuberculosis treatment in Kyrgyzstan stood at 1,607 constant 2022 US$.
Compared with earlier readings it is down 10.6% on the previous year and down 54.4% over ten years.
That places Kyrgyzstan 29th out of 92 countries with data for 2022, putting it in the middle of the range.
Average cost of multi drug-resistant tuberculosis treatment in Kyrgyzstan, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 3,525 constant 2022 US$ | — |
| 2018 | 1,250 constant 2022 US$ | -64.5% |
| 2019 | 1,878 constant 2022 US$ | +50.2% |
| 2020 | 1,878 constant 2022 US$ | +0.0% |
| 2021 | 1,797 constant 2022 US$ | -4.3% |
| 2022 | 1,607 constant 2022 US$ | -10.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 2,218 constant 2022 US$ | 1,250 constant 2022 US$ | 3,525 constant 2022 US$ | 3 |
| 2020s | 1,761 constant 2022 US$ | 1,607 constant 2022 US$ | 1,878 constant 2022 US$ | 3 |
Countries ranked near Kyrgyzstan
More health data for Kyrgyzstan
- Un projection of annual infant deaths, annual growth rate -1.77 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6971 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 938.9 deaths per 1,000 people (2090)
- Number of infants who die before age 1 278 deaths (2100)
- Population ages 05-09, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, female, per capita 0.0545 units per person (2025)
- Population ages 05-09, male, annual growth rate 0.8174 % change on previous year (2025)
- Population ages 05-09, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 05-09, male, per capita 0.0573 units per person (2025)
- Population ages 10-14, female, annual growth rate 2.23 % change on previous year (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in Kyrgyzstan?
- Average cost of multi drug-resistant tuberculosis treatment in Kyrgyzstan was 1,607 constant 2022 US$ in 2022, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in Kyrgyzstan?
- The highest recorded value was 3,525 constant 2022 US$ in 2017.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in Kyrgyzstan?
- The lowest recorded value was 1,250 constant 2022 US$ in 2018.
- How does Kyrgyzstan rank for average cost of multi drug-resistant tuberculosis treatment?
- Kyrgyzstan ranks 29th out of 92 countries with data for 2022.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in Kyrgyzstan?
- Over the last ten years it is down 54.4%. The long-run trend across the full record is falling.
- Where does this Kyrgyzstan data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 6 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.